FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christine Richer

Research Profile

Living Beings

Physiology

Disorders

Chemicals & Drugs

Anatomy

Myocardium

Co-author Network

Publications

TOP 3
Louis Potier; Christine Richer; Ronan Roussel; Ludovic Waeckel; Nadine Bouby; Francois Alhenc-Gelas
Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency.
Gaia Spinetti; Orazio Fortunato; Daniela Cordella; Paola Portararo; Nicolle Kraenkel; Rajesh G Katare; Graciela B Sala-Newby; Christine Richer; Marie-Pascale Vincent; François Alhenc-Gelas; Giancarlo Tonolo; Sara Cherchi; Costanza Emanueli; Paolo Madeddu
Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.
François Alhenc-Gelas; Nadine Bouby; Louis Potier; Christine Richer; Ronan Roussel; Michel Marre
Kinins as therapeutic agents in cardiovascular and renal diseases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christine Richer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Louis Potier; Christine Richer; Ronan Roussel; Ludovic Waeckel; Nadine Bouby; Francois Alhenc-Gelas
Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency.
Biological chemistry 2013;394(3):329-33.
2011: Gaia Spinetti; Orazio Fortunato; Daniela Cordella; Paola Portararo; Nicolle Kraenkel; Rajesh G Katare; Graciela B Sala-Newby; Christine Richer; Marie-Pascale Vincent; François Alhenc-Gelas; Giancarlo Tonolo; Sara Cherchi; Costanza Emanueli; Paolo Madeddu
Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.
Circulation research 2011;108(3):284-93.
2011: François Alhenc-Gelas; Nadine Bouby; Louis Potier; Christine Richer; Ronan Roussel; Michel Marre
Kinins as therapeutic agents in cardiovascular and renal diseases.
Current pharmaceutical design 2011;17(25):2654-62.
2010: Erij Messadi; Marie-Pascale Vincent; Violaine Griol-Charhbili; Chantal Mandet; Juliana Colucci; John H Krege; Patrick Bruneval; Nadine Bouby; Oliver Smithies; François Alhenc-Gelas; Christine Richer
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(12):4691-700.
2009: Violaine Griol-Charhbili; Laurent Sabbah; Juliana Colucci; Marie-Pascale Vincent; Véronique Baudrie; Dominique Laude; Jean-Luc Elghozi; Patrick Bruneval; Nicolas Picard; Pierre Meneton; François Alhenc-Gelas; Christine Richer
Tissue kallikrein deficiency and renovascular hypertension in the mouse.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;296(5):R1385-91.
2009: Oliver A Stone; Christine Richer; Costanza Emanueli; Vincent van Weel; Paul H A Quax; Rajesh Katare; Nicolle Kraenkel; Paola Campagnolo; Luciola S Barcelos; Mauro Siragusa; Graciela B Sala-Newby; Danila Baldessari; Marina Mione; Marie P Vincent; Andrew V Benest; Ayman Al Haj Zen; Julien Gonzalez; David O Bates; François Alhenc-Gelas; Paolo Madeddu
Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(5):657-64.
2008: Anne Pizard; Christine Richer; Nadine Bouby; Nicolas Picard; Pierre Meneton; Michel Azizi; François Alhenc-Gelas
Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.
Biological chemistry 2008;389(6):701-6.
2008: Sandrine Pons; Violaine Griol-Charhbili; Christophe Heymes; Paul Fornes; Didier Heudes; Albert Hagege; Xavier LOYER; Pierre Meneton; Jean-François Giudicelli; Jane-Lise Samuel; François Alhenc-Gelas; Christine Richer
Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice.
European journal of heart failure 2008;10(4):343-51.
2008: E Messadi-Laribi; Violaine Griol-Charhbili; E Gaies; M P Vincent; Didier Heudes; Pierre Meneton; François Alhenc-Gelas; Christine Richer
Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Clinical and experimental pharmacology & physiology 2008;35(4):489-93.
2007: Erij Messadi-Laribi; Violaine Griol-Charhbili; Anne Pizard; Marie-Pascale Vincent; Didier Heudes; Pierre Meneton; François Alhenc-Gelas; Christine Richer
Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
The Journal of pharmacology and experimental therapeutics 2007;323(1):210-6.
2006: Paolo Madeddu; Costanza Emanueli; Frank Spillmann; M Meloni; Nadine Bouby; Christine Richer; François Alhenc-Gelas; Vincent van Weel; Daniel Eefting; Paul H A Quax; Y Hu; Q Xu; A L Hemdahl; Jolanda van Golde; M Huijberts; Q de Lussanet; H Struijker Boudier; thierry couffinhal; C Duplaa; S Chimenti; Lidia Staszewsky; R Latini; V Baumans; B I Levy
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems.
Vascular pharmacology 2006;45(5):281-301.
2005: Violaine Griol-Charhbili; E Messadi-Laribi; J L Bascands; Didier Heudes; Pierre Meneton; Jean-François Giudicelli; François Alhenc-Gelas; Christine Richer
Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(9):1172-4.
2005: Anne Royer; Toon A B van Veen; Sabrina Le Bouter; Céline Marionneau; Violaine Griol-Charhbili; Anne-Laure Léoni; Marja Steenman; Harold V M van Rijen; Sophie Demolombe; Catharine Goddard; Christine Richer; Brigitte Escoubet; Thérèse Jarry-Guichard; William H Colledge; Daniel Gros; Jacques M T de Bakker; Andrew A Grace; Denis Escande; Flavien Charpentier
Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis.
Circulation 2005;111(14):1738-46.
2003: Sandrine Pons; Albert A Hagège; Paul Fornes; Marianne Gervais; Jean-François Giudicelli; Christine Richer
Effects of angiotensin II type 1 receptor blockade in ApoE-deficient mice with post-ischemic heart failure.
Journal of cardiovascular pharmacology 2003;42(1):17-23.
2003: Marianne Gervais; Sandrine Pons; Antonino Nicoletti; Claudine Cosson; Jean-François Giudicelli; Christine Richer
Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(2):183-9.
2003: Sandrine Pons; Paul Fornes; Albert A Hagege; Didier Heudes; Jean-François Giudicelli; Christine Richer
Survival, haemodynamics and cardiac remodelling follow up in mice after myocardial infarction.
Clinical and experimental pharmacology & physiology 2003;30(1-2):25-31.
2002: Nathalie Kubis; Christine Richer; Valérie Domergue; Jean-François Giudicelli; Bernard I Lévy
Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt-/- ).
Journal of hypertension 2002;20(8):1581-7.
2001: Christine Richer; Valérie Domergue; Marianne Gervais; Paul Fornes; F Trabold; Jean-François Giudicelli
Coronary dilatation reserve in experimental hypertension and chronic heart failure: effects of blockade of the renin-angiotensin system.
Clinical and experimental pharmacology & physiology 2001;28(12):997-1001.
2001: Christine Richer; Paul Fornes; Valérie Domergue; M De Gasparo; Jean-François Giudicelli
Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats.
Journal of cardiac failure 2001;7(3):269-76.
2000: Christine Richer; Valérie Domergue; Marianne Gervais; P Bruneval; Jean-François Giudicelli
Fluospheres for cardiovascular phenotyping genetically modified mice.
Journal of cardiovascular pharmacology 2000;36(3):396-404.
2000: Marianne Gervais; Paul Fornes; Christine Richer; Dino Nisato; Jean-François Giudicelli
Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats.
Journal of cardiovascular pharmacology 2000;36(3):329-37.
2000: Khaled Zeghal; Zouhaier Sahnoun; M Guinot; Christine Richer; Jean-François Giudicelli
Characterization and mechanisms of the cardiovascular and haemodynamic alterations induced by scorpion venom in rats.
Fundamental & clinical pharmacology 2000;14(4):351-61.
1999: Christine Richer; Marianne Gervais; Paul Fornes; Jean-François Giudicelli
Combined selective angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats.
Journal of cardiovascular pharmacology 1999;34(6):772-81.
1999: I Espinasse; V Iourgenko; Christine Richer; Michèle Heimburger; Nicole Defer; M C Bourin; F Samson; E Pussard; Jean-François Giudicelli; Jean-Baptiste Michel; Jacques Hanoune; Jean-Jacques Mercadier
Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure.
Cardiovascular research 1999;42(1):87-98.
1999: Marianne Gervais; Pierre Démolis; Valérie Domergue; M Lesage; Christine Richer; Jean-François Giudicelli
Systemic and regional hemodynamics assessment in rats with fluorescent microspheres.
Journal of cardiovascular pharmacology 1999;33(3):425-32.
1999: Marianne Gervais; Christine Richer; Paul Fornes; M De Gasparo; Jean-François Giudicelli
Valsartan and coronary haemodynamics in early post-myocardial infarction in rats.
Fundamental & clinical pharmacology 1999;13(6):635-45.
1999: Christine Richer; Paul Fornes; C Cazaubon; Valérie Domergue; Dino Nisato; Jean-François Giudicelli
Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.
Cardiovascular research 1999;41(1):100-8.
1998: Christine Richer; P Bruneval; Joël Ménard; Jean-François Giudicelli
Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
Hypertension 1998;31(2):692-8.
1997: Christine Richer; E Vacher; Paul Fornes; Jean-François Giudicelli
Antihypertensive drugs in the stroke-prone spontaneously hypertensive rat.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1997;19(5-6):925-36.
1996: Christine Richer; H Boulanger; S Es-Slami; Jean-François Giudicelli
Lack of beneficial effects on the NO-donor, molsidomine, in the L-NAME-induced pre-eclamptic syndrome in pregnant rats.
British journal of pharmacology 1996;119(8):1642-8.
1996: E Vacher; Christine Richer; Jean-François Giudicelli
Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats.
Journal of hypertension 1996;14(11):1341-8.
1996: E Vacher; Christine Richer; Paul Fornes; J P Clozel
Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1996;27(5):686-94.
1996: Christine Richer; Valérie Domergue; M P Vincent; Jean-François Giudicelli
Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
British journal of pharmacology 1996;117(2):315-24.
1995: B Chauvin; Christine Richer; Jean-François Giudicelli
Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
British journal of pharmacology 1995;116(4):2229-36.
1995: E Vacher; Paul Fornes; Christine Richer; P Bruneval; Dino Nisato; Jean-François Giudicelli
Early and late haemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development.
Journal of hypertension 1995;13(6):675-82.
1995: E Vacher; Christine Richer; C Cazaubon; Paul Fornes; Dino Nisato; Jean-François Giudicelli
Are vasopressin peripheral V1 receptors involved in the development of malignant hypertension and stroke in SHR-SPs?
Fundamental & clinical pharmacology 1995;9(5):469-78.
1994: Christine Richer; Paul Fornes; E Vacher; P Bruneval; Jean-François Giudicelli
Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist long after treatment withdrawal.
The American journal of cardiology 1994;73(10):26C-35C.
1993: E Vacher; Paul Fornes; Valérie Domergue; Christine Richer; P Bruneval; Jean-François Giudicelli
Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
American journal of hypertension 1993;6(11 Pt 1):951-9.
1993: N Moreau; Christine Richer; M P Vincent; Jean-François Giudicelli
[Interaction between SR 47436, a new angiotensin II antagonist and sympathetic nervous system in pithed SHR rats].
Archives des maladies du coeur et des vaisseaux 1993;86(8):1269-74.
1993: Paul Fornes; Christine Richer; E Vacher; P Bruneval; Jean-François Giudicelli
Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.
Journal of cardiovascular pharmacology 1993;22(2):305-13.
1993: N Moreau; Christine Richer; M P Vincent; Jean-François Giudicelli
Sympathoinhibitory effects of losartan in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1993;22(1):126-34.
1992: Paul Fornes; Christine Richer; E Pussard; Didier Heudes; Valérie Domergue; Jean-François Giudicelli
Beneficial effects of trandolapril on experimentally induced congestive heart failure in rats.
The American journal of cardiology 1992;70(12):43D-51D.
1992: Christine Richer; P Mulder; Paul Fornes; Valérie Domergue; Didier Heudes; Jean-François Giudicelli
Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.
Journal of cardiovascular pharmacology 1992;20(1):147-56.
1991: Christine Richer; P Mulder; Paul Fornes; V Richard; J P Camilleri; Jean-François Giudicelli
Hemodynamic and morphological effects of quinapril during genetic hypertension development.
Journal of cardiovascular pharmacology 1991;18(4):631-42.
1991: Jean-François Giudicelli; Christine Richer; C Richard; C Thuillez
Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
American journal of hypertension 1991;4(3 Pt 2):258S-262S.
1990: Christine Richer; P Mulder; M P Doussau; P Gautier; Jean-François Giudicelli
Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.
British journal of pharmacology 1990;100(3):557-63.
1989: Christine Richer; M P Doussau; Jean-François Giudicelli
Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1989;3(6):865-72.
1989: Christine Richer; P Mulder; M P Doussau; Jean-François Giudicelli
[Potassium agonists: regional vasodilator profile in rats].
Archives des maladies du coeur et des vaisseaux 1989;82(7):1333-7.
1989: E Scalbert; Christine Richer; Jean-François Giudicelli
Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
Journal of cardiovascular pharmacology 1989;13(1):94-104.
1988: E Scalbert; Christine Richer; Jean-François Giudicelli
Lack of presynaptic effects of ketanserin on cardiac noradrenergic nerve terminals in the SHR.
Fundamental & clinical pharmacology 1988;2(4):295-9.
1987: Christine Richer; E Scalbert; M P Doussau; P Duhaze; Jean-François Giudicelli
Ketanserin: systemic and regional hemodynamics in spontaneously hypertensive rats. Role of alpha 1-adrenoceptor blockade.
European journal of pharmacology 1987;139(1):31-42.
1987: Christine Richer; M P Doussau; Jean-François Giudicelli
[Atrial natriuretic factor. Systemic and regional hemodynamic profile and interaction with the alpha-adrenergic system in pithed SHR rats].
Archives des maladies du coeur et des vaisseaux 1987;80(6):970-5.
1987: Christine Richer; M P Doussau; Jean-François Giudicelli
Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.
The American journal of cardiology 1987;59(10):12D-17D.
1986: Christine Richer; M P Doussau; Jean-François Giudicelli
Systemic and regional pre- and post-junctional sympathoinhibitory effect of perindopril in spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1986;4(3):S513-6.
1986: Christine Richer; M P Doussau; Jean-François Giudicelli
Perindopril, a new converting enzyme inhibitor: systemic and regional hemodynamics and sympathoinhibitory effects in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1986;8(2):346-57.
1984: Christine Richer; M P Doussau; Jean-François Giudicelli
Influence of captopril and enalapril on regional vascular alpha-adrenergic receptor reactivity in SHR.
Hypertension 1984;6(5):666-74.
1983: Christine Richer; M P Doussau; Jean-François Giudicelli
Postsynaptic alpha adrenoceptors and attenuation of vascular sympathetic responses in SHRs by captopril and enalapril.
European heart journal 1983;4 Suppl G():55-60.
1983: Christine Richer; M P Doussau; Jean-François Giudicelli
Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
Hypertension 1983;5(3):312-20.
1982: Christine Richer; M P Doussau; Jean-François Giudicelli
[Prevention of the development of genetic hypertension by MK 421 in the SHR].
Archives des maladies du coeur et des vaisseaux 1982;75 Spec No():55-8.
1982: Christine Richer; M P Doussau; Jean-François Giudicelli
MK 421 and prevention of genetic hypertension development in young spontaneously hypertensive rats.
European journal of pharmacology 1982;79(1-2):23-9.